Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy-Reference-Cited by-同舟云学术

Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy

Published:2018-10 Issue: Volume:52 Page:103-109
ISSN:1044-579X
Container-title:Seminars in Cancer Biology
language:en
Short-container-title:Seminars in Cancer Biology

Author:

Osmani Lais,Askin Frederic,Gabrielson Edward,Li Qing Kay

Publisher

Elsevier BV

Subject

Cancer Research

Reference37 articles.

1. Cancer statistics;Siegel;CA. Cancer J. Clin.,2017

2. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart;Travis,2015

3. WHO panel. the 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification;Travis;J. Thorac. Oncol.,2015

4. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

5. Erlotinib in lung cancer—molecular and clinical predictors of outcome;Tsao;N. Engl. J. Med.,2005

Cited by 567 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triazole-based Mn(II), Fe(II), Ni(II), Cu(II) and Zn(II) complexes as potential anticancer agents – Physicochemical properties, in silico predictions and in vitro activity;Polyhedron;2024-10

2. Photonanozyme–Kras–ribosome combination treatment of non-small cell lung cancer after COVID-19;Frontiers in Immunology;2024-09-06

3. Tumor markers in non-small cell lung cancer spine metastasis: an assessment of prognosis and overall survival;European Spine Journal;2024-09-02

4. Isotoosendanin exerts anti-tumor effects in NSCLC by enhancing the stability of SHP-2 and inhibiting the JAK/STAT3 pathway;Phytomedicine;2024-09

5. Development of Ex Vivo Analysis for Examining Cell Composition, Immunological Landscape, Tumor and Immune Related Markers in Non-Small-Cell Lung Cancer;Cancers;2024-08-20